Boardroom Alpha
Boardroom Alpha
TZOO · Current Report (Form 8-K) · Filed April 20, 2026

Travelzoo — Current Report (Form 8-K)

Form
8-K
Filed
April 20, 2026
Period
Apr 20, 2026
Ticker
TZOO
Accession
0001133311-26-000007
Boardroom Alpha · Filing insights

Stockholders approved CEO Holger Bartel's 600,000-share stock option grant; board elections and other executive option grants were approved.

About Travelzoo
Market cap
$70M
1Y TSR
−26.2%
3Y TSR
+1.4%
Board grade
B-
Sector
Communication Services
CEO
Holger Bartel
Last annual meeting: Apr 20, 2026 · View full Travelzoo profile →
tzoo-20260420


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________________________________________
FORM 8-K
____________________________________________________
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  April 20, 2026
____________________________________________________

image0a212a14.jpg
(Exact name of registrant as specified in its charter)
____________________________________________________
Delaware000-5017136-4415727
(State or Other
Jurisdiction of
Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
590 Madison Avenue, 35th Floor
New York, New York
10022
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code +1 212 516-1300
(Former Name or Former Address, if Changed Since Last Report)
____________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueTZOOThe NASDAQ Stock Market




Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
                                         Emerging growth company        

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  




Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Option Grant to Holger Bartel, Global Chief Executive Officer

On February 19, 2026, Travelzoo (the “Company”) entered into a Nonqualified Stock Option Agreement (the “HB Option Agreement”) with Holger Bartel, Global Chief Executive Officer, pursuant to which the Company granted Mr. Bartel the option to purchase 600,000 shares of the Company’s common stock (such option being hereinafter referred to as the “HB Option”). The Compensation Committee of the Board of Directors of the Company (the “Committee) engaged an independent compensation consultant to advise on the terms of the HB Option. The HB Option Agreement and the HB Option were subject to approval by the stockholders of the Company.

The Committee, which is comprised solely of independent directors, unanimously approved the HB Option and the HB Option Agreement after confirming with an independent compensation consultant that both are in line with historical practices of the Company and market practice. On April 20, 2026, the stockholders of the Company approved the HB Option Agreement and the HB Option.

The exercise price of the HB Option is $5.05 per share. The HB Option will vest semi-annually over two years in equal installments of 25%, with first vesting on June 30, 2026. The HB Option cannot be exercised after the expiration of the term of the HB Option, which is five (5) years from the date of grant.

The information set forth above relating to the HB Option Agreement between the Company and Mr. Bartel is qualified in its entirety by reference to the full text of the agreement, which was attached as an appendix to the Company’s Schedule 14A, filed with the Securities and Exchange Commission (SEC) on March 11, 2026, and which is incorporated by reference herein.
Item 5.07    Submission of Matters to a Vote of Security Holders.
 
At the 2026 Annual Meeting of Stockholders of Travelzoo held on April 20, 2026 via webcast, at www.virtualshareholdermeeting.com/TZOO2026, the following actions were taken.

Travelzoo's stockholders elected Ralph Bartel, Christina Sindoni Ciocca, Volodymyr Cherevko, Michael Karg and Sharry Sun to serve on the Board of Directors until the next annual meeting of stockholders. The voting results are:

 Votes ForVotes AgainstVotes Withheld
Ralph Bartel6,112,249 282,942 2,638 
Christina Sindoni Ciocca6,190,512 204,332 2,985 
Volodymyr Cherevko5,996,040 397,893 3,896 
Michael Karg6,171,042 223,449 3,338 
Sharry Sun6,312,744 82,512 2,573 
Mr. Cherevko, Mr. Karg and Ms. Sun will serve as independent directors in accordance with the listing standards of the NASDAQ Stock Market.
The proposal regarding the stock option grant to the Global Chief Executive Officer was approved. The voting results are:
Votes ForVotes AgainstAbstain
4,478,7371,908,52410,568
The proposal regarding the stock option grant to the General Manager, U.S. was approved. The voting results are:
Votes ForVotes AgainstAbstain
5,029,2551,357,45611,118
The proposal regarding the stock option grant to the Head of Engineering was approved. The voting results are:
Votes ForVotes AgainstAbstain
5,029,9061,357,37910,544



The stockholders approved, on an advisory basis, Travelzoo’s executive compensation. The voting results are:
Votes ForVotes AgainstAbstain
6,216,201170,68310,945





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TRAVELZOO
Date:April 20, 2026By:/s/ JEFF HOFFMAN
Jeff Hoffman
Financial Controller, North America



















































EXHIBIT INDEX
ExhibitDescription
Nonqualified Stock Option Agreement between Travelzoo and Holger Bartel, dated February 19, 2026 (Incorporated by reference to Appendix A on Form DEF 14A (File No. 000-50171), filed March 11, 2026)

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Travelzoo (TZOO)

Reference

Frequently asked questions

When did Travelzoo file this 8-K?
Travelzoo (TZOO) filed this Current Report (Form 8-K) with the SEC on April 20, 2026. The accession number assigned by EDGAR is 0001133311-26-000007.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders approved CEO Holger Bartel's 600,000-share stock option grant; board elections and other executive option grants were approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Travelzoo's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Travelzoo has filed under CIK 1133311, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer